Respiratory
Boehringer Ingelheim has over 90 years of heritage in managing respiratory disease. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life
"On Air" The series - EP.5 Director: How can we rationally use ICS in COPD?
10/05/2024 | Author: Boehringer Ingelheim
Document ID: PC-TH-104699
RELATED CONTENT
23:31
Hightlight Symposium "Journey of Resvolution in COPD"_Dr. Patharapan Lersritwimanmaen, M.D._Siriraj Hospital
20:49
Hightlight Symposium TST annual meeting 2025_Global COPD Guideline 2025: Unveiling the Mystery_ Prof. Dr. Kittipong Maneechotesuwan
09:07
Rerun Multiverse: Treatment During the Time of Hospitalization for Exacerbation by Col.Amornchai L.
14:38
Rerun Penetration: Produce Mist to Reduce Misses by Assoc.Prof.Yuda S.
17:35
Rerun S.H.I.E.L.D.: Disarming ICS in COPD Patients with non-ICS Benefits by Dr.Nadwipa Y.
12:16